MENU
+Compare
EXAS
Stock ticker: NASDAQ
AS OF
Apr 3, 01:08 PM (EDT)
Price
$43.88
Change
-$0.68 (-1.53%)
Capitalization
12.78B

EXAS Exact Sciences Corp Forecast, Technical & Fundamental Analysis

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally... Show more

Industry: #Biotechnology
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EXAS with price predictions
Apr 02, 2025

EXAS in upward trend: price may jump up because it broke its lower Bollinger Band on March 13, 2025

EXAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 41 cases where EXAS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EXAS's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for EXAS just turned positive on March 19, 2025. Looking at past instances where EXAS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EXAS advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EXAS as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXAS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EXAS entered a downward trend on March 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.065) is normal, around the industry mean (23.715). P/E Ratio (0.000) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.074) is also within normal values, averaging (41.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EXAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EXAS is expected to report earnings to rise 454.67% to -33 cents per share on May 07

Exact Sciences Corp EXAS Stock Earnings Reports
Q1'25
Est.
$-0.33
Q4'24
Beat
by $0.27
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.25
Q1'24
Missed
by $0.12
The last earnings report on February 19 showed earnings per share of -5 cents, beating the estimate of -33 cents. With 327.00K shares outstanding, the current market capitalization sits at 12.78B.
A.I. Advisor
published General Information

General Information

a developer of proprietary technologies for the detection of cancer

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5505 Endeavor Lane
Phone
+1 608 284-5700
Employees
6600
Web
https://www.exactsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PPEM21.610.08
+0.38%
Putnam PanAgora ESG Emerg Mkts Eq ETF
QKC.X0.006148-0.000388
-5.94%
QuarkChain cryptocurrency
MDT.X0.023495-0.001568
-6.26%
Measurable Data Token cryptocurrency
LRC.X0.093144-0.006253
-6.29%
Loopring cryptocurrency
GALA.X0.014567-0.001305
-8.22%
Gala cryptocurrency

EXAS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EXAS has been loosely correlated with QGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAS jumps, then QGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXAS
1D Price
Change %
EXAS100%
+2.55%
QGEN - EXAS
55%
Loosely correlated
+1.32%
RGEN - EXAS
55%
Loosely correlated
+1.88%
FNA - EXAS
32%
Poorly correlated
+0.15%
ATEC - EXAS
29%
Poorly correlated
+3.67%
NAOV - EXAS
29%
Poorly correlated
-16.07%
More